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Summary
A syndrome with urgency, with or without associated urine incontinence and usually accom-
panied by higher urinary frequency and nocturia has been named “overactive bladder; OAB”. 
OAB is an entity with complex pathophysiology, involving both myogenic and neurogenic 
(afferent / efferent bladder innervation) disturbances. OAB symptoms accompany benign 
prostatic hypertrophy - BPH (“obstructive OAB”). The aim of the study was to estimate the 
autonomic nervous system activity (ANS) in the experimental bladder outlet obstruction 
(BOO) which was an animal model of the human BPH. The study was conducted using 30 
female rats, divided into two groups: BOO animals (n=15), with surgically induced BOO (by 
partial ligation of the proximal urethra) and control ones (n=15), which underwent sham pro-
cedure (without urethral ligation). Two weeks after the surgery, in both groups, ANS activity 
was estimated using time- and spectral analysis of the heart rate variability recordings. The 
bladder overactivity in BOO animals was confirmed using urodynamic recordings and bladder 
histological assessment, juxtaposed against the results of the control group. The key finding 
of our study was the development of autonomic disturbances in bladder outlet obstruction 
(BOO) rats. Our study revealed that BOO animals were characterised by diminished rMSSD 
and spectral HRV parameters: TP, LF and HF, in comparison with the control group. The 
normalised nLF and nHF parameters did not differ significantly in both groups, although 
slight changes in the nLF (increased) and nHF (decreased) were noted in BOO group. The 
absolute VLF value was almost the same in both studied populations, however, the percentage 
part of this component in the appropriate HRV spectrum differed considerably in both studied 
groups. In BOO animals, VLF percentage amounted to about 90%, whereas in control animals 
this parameter reached only about 53% of the total power spectrum.  
Thus, to sum up, our findings suggest autonomic imbalance with decreased global autonomic 
tension and diminished parasympathetic activity with relatively sympathetic overactivity. 
bladder outlet obstruction (BOO) • overactive bladder (OAB) • autonomic nervous system (ANS)
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IntroductIon
The main bladder function is to store urine in the filling 
period, during the continuous process of urine forma-
tion by the kidneys and to remove urine during discon-
tinuous voiding process. Bladder functioning implicates 
cooperation of many regulatory mechanisms, involving 
afferent pathways sensing bladder filling and distension, 
central nervous processing of such signals and effector 
pathways enabling urine storage and voiding. The di-
sturbances of complex mechanisms mentioned above 
result in voiding dysfunction. It may occur in the form 
of too frequent micturition with or without inadequate 
timing, insufficient micturition or involuntary micturi-
tion. A syndrome with urgency, with or without asso-
ciated urine incontinence and usually accompanied by 
higher urinary frequency and nocturia has been named 
“overactive bladder; OAB” [24]. Urgency is characterised 
as a sudden, compelling desire to pass urine and a higher 
voiding frequency means that according to a patient, he/
she voids too often by day; nocturia is defined as a need 
to wake at night to pass urine [24,26]. The involuntary 
detrusor contractions during filling period are regar-
ded to be of essential pathophysiological meaning in 
OAB. The detailed description of bladder physiological 
aspects and the neurogenic and myogenic theories on 
OAB pathophysiology have been given in many reviews 
[1,5,13], including our ones [8,9] and crosses the frames 
of the present study.
It is obvious that bladder functioning is under control of 
many physiological and pathophysiological factors invo-
lving local pathologies, such as bladder outlet obstruc-
tion (BOO). It is an entity of special clinical meaning 
in view of the fact that patients with benign prostatic 
enlargement (benign prostatic hypertrophy; BPH) di-
splay OAB symptoms due to BOO – both arising from 
abnormal voiding (weak stream) as well as irritative 
symptoms involving impaired bladder storage function 
(frequency, nocturia, urgency). It must be stressed that 
BOO surgical relief does not completely abolish OAB 
symptoms, thus, operated male patients with BPH often 
still exhibit storage symptoms with resolving voiding 
disturbances. Such alternation may be a result of the 
gross anatomical, histological and functional bladder 
rearrangement [24].
Bladder rebuilding during BOO may be studied in both 
humans and experimental models. In general, several in-
duced animal models have been developed to study OAB 
pathophysiology, whereby a relevant pathophysiological 
condition is experimentally applied to a healthy animal to 
mimic the human challenge.
Effects similar to BOO in humans are relatively straight-
forward to replicate in animals by partial obstruction of 
the urethra development that narrows the urethra imme-
diately or does so gradually as the immature animals grow. 
The experimental BOO model reveals many structural and 
functional bladder changes, including total bladder enlar-
gement (that develops over months and years in humans, 
but over days and weeks in animals), smooth muscle cells 
hypertrophy of the bladder wall, patchy denervation of 
detrusor muscle, increased spontaneous myogenic activity 
with non-micturition contractions [26].  One of the stu-
dies to confirm bladder wall rebuilding was Pampinella et 
al. [25], an experimental work, which demonstrated po-
stnatal structural bladder changes after 7 and 30 days of 
obstruction in immature, 30-day-old rabbits. In bladder 
histological specimen assessment they showed accelera-
tion of the fibroblasts conversion to smooth muscle cells 
and their spatial differentiation and specific arrangement 
in the serosa. Thus, they demonstrated that BOO leads to 
the overall bladder weight increase and bladder wall mu-
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scurisation. Together with bladder wall rebuilding, blad-
der autonomic innervation was also observed. Gosling et 
al. [11] revealed in their histological study a significant 
reduction in the amount of autonomic nerve supplying 
detrusor in obstructed patients, thus proving again that 
functional impairment of the urinary bladder occurs in 
response to outflow obstruction. These findings have been 
confirmed by experimental studies. Tammela and Lasa-
nen estimated the effect of distension on both adrenergic 
[31] and cholinergic [17] innervation in the rat urinary 
bladder. They demonstrated depletion of catecholamines 
in the early period after bladder obstruction with almost 
complete recovery throughout the 21-day study period. 
Hence, according to Tammela and Lasanen, the primary 
clinical success of distension therapy for the treatment of 
OAB may be at least partly due to a reversible disturban-
ce in the function of adrenergic nerves [31].  Moreover, 
the same researchers showed cholinergic hypoinnervation 
7 days after bladder distension, persisting up to 21 days, 
with an increase of cholinergic nerves in the longer period 
of the observation. Thus, their findings indicate transient 
cholinergic innervation damage, which may in turn explain 
the prolonged voiding difficulties often observed after ca-
theterisation of an overdistended bladder in patients with 
urinary retention. Similarly to their previous results, they 
suggested that the short-lasting effect of bladder dilatation 
therapy used to treat detrusor instability may also be due 
to the fairly rapid regeneration of cholinergic innervation 
[19]. Additionally, apart from cholinergic and adrenergic 
differences in obstructed bladders, alternation of purinergic 
signalling in this model was also found. The experimen-
tal study by Calvert et al. [3] supported earlier findings 
of impaired cholinergic decrease in the early period after 
bladder obstruction, but they also demonstrated that blad-
der purinergic nervous component was at the same time 
increased. In another experimental study, Lluel et al [18] 
revealed through a rat model of BOO that in long-lasting 
obstruction increased basal tone of cholinergic neurotran-
smission occurs, according to them, due to proliferation of 
pre-existing cholinergic nerves that become functionally 
more important than the cholinergic-purinergic nerves 
which predominate physiologically [18].
To sum up, many clinical and animal studies confirmed 
abnormal detrusor contractility in BOO, resulting from 
overall myoelectrical and mechanical disturbed functio-
ning of the bladder smooth muscles (consistently with the 
general OAB myogenic theory) as well as from impaired 
bladder innervation and its response to various stimuli. 
In conclusion, the filling symptoms typically observed in 
BOO patients or experimental animals could be explained 
as increased muscarinic or excitatory α-1 adrenergic blad-
der input or decreased inhibitory β-adrenergic pathways. 
However, it seems that cholinergic impairment has larger 
role in BOO pathophysiology as it is more dominant in 
the bladder [24].
Against the background of the reports indicating distur-
bed bladder autonomic supplying and its warped functio-
ning, the studies estimating global autonomic activity in 
the course of BOO are scant. Thus, we tried to evaluate 
indirectly the autonomic nervous system (ANS) functio-
ning in experimental model of bladder outlet obstruction 
using the heart rate variability (HRV) method. Nowadays, 
HRV is considered to be one of the best ANS assessment 
methods (both in experimental and clinical conditions), 
based on the measurement of the variability of the R-R 
intervals in [ms] in ECG signal in participants with do-
minant sinus rhythm [2,30]. There are two main types 
of HRV analysis: time domain and spectral (frequency) 
domain analyses. The first one is directly based on the 
main studied parameter – mean R-R [ms]; also known 
as mean normal-normal (mNN [ms]) and several statisti-
cally derived parameters. In general, the higher increase 
of R-R intervals variability is demonstrated, the more 
pronounced heart autonomic control occurs, which also 
suggests a higher global autonomic tension. The former 
analysis is associated with so-called HRV spectrum that 
is a result of ECG signal transformation using special 
mathematical operating – fast Fourier transformation. In 
short (usually lasting 5-30 minutes) recordings one can 
distinguish three main spectral components, expressed in 
power units [ms*ms] – VLF (at a very low frequency of 
the HRV spectrum), LF (at a low frequency) and HF (at 
a high frequency) and total power – TP of the spectrum. 
There are also normalised LF – nLF and normalised HF 
– nHF values, expressed in normalised units [n.u.] and 
derived as a result of referring of the appropriate (LF/
HF) component to the total power spectrum dimini-
shing of VLF spectrum. These spectral parameters are 
regarded to reflect global autonomic tension (TP), com-
mon sympathetic and parasympathetic activity (LF) as 
well as pure parasympathetic (HF, nHF) or sympathe-
tic (nLF) tension. There is no consensus as to the VLF 
interpretation, as this component is regarded to reflect 
various, short-term autonomic activities associated with 
thermoregulatory, endocrine, heart and vasomotor (renin-
-angiotensin-aldosterone system) responses that may be 
mediated mostly by sympathetic but also potentially by 
the parasympathetic ANS branch. Detailed information 
related to the HRV methodology is contained in the 
HRV guidelines [21] and some reviews [27].
MaterIals and Methods
Ethics: The study protocol was approved by the First 
Local Ethic Committee in Cracow (agreement decision 
126/2010). 
Animals, studied groups and general study plan: The 
animals were obtained from the central laboratory. Upon 
arrival at the animal house of Pathophysiology Depart-
ment, the rats were allowed an acclimatisation period of 
one week in groups of five per cage. The animals were 
housed at room temperature, with 12-12 hours day-night 
cycle, with standard food (Labofeed Kcynia) and water 
ad libitum. 
After the acclimatisation period, the animals were ran-
domised into study groups of the animals with surgical-
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ly induced proximal bladder outlet obstruction – BOO 
(mean body weight 243,3±13,5g) and the control group 
(mean body weight 236,3±6,3g). Each group consisted of 
15 female 10-week-old Wistar rats, thus the experiment 
was carried out using 30 animals. We planned to perform 
HRV recordings with statistical BOO/control differences 
analysis, urodynamic bladder functioning estimation and 
bladders macroscopic and histological assessment in both 
BOO and control animals.
BOO model: Animals enrolled into the BOO group 
underwent surgery procedure to induce partial urine 
outflow obstruction, leading to bladder overactivity. The 
technique used to obtain a bladder outlet obstruction, 
both in growing and mature animals, has already been 
described in the 1980s by some investigators – for exam-
ple Sibley (1985) [28], Kato et al. (1988) [16] or Har-
rison et al. (1990) [12] and it is still used with small 
modifications by many other researchers (e.x. Das et 
al ; 2002 [6], Kamiyama et al ; 2007 [15], de Jongh et 
al ; 2007 [7]).
The rats were briefly anesthetised with sodium pentobar-
bital (Morbital, Biowet, Puławy; 35mg/kg body weight) 
intraperitoneally. Under general anaesthesia, a 1mm dia-
meter stainless urinary catheter was placed in the ure-
thra. After performing a lower midline laparotomy, the 
bladder and proximal urethra were exposed and a 4/0 silk 
ligature was tied around the proximal urethra and the 
inserted rod. Then the catheter was removed leaving the 
urethra partially occluded. The laparotomy incision was 
then closed, two antibiotics (neomycinum – Neomycin 
spray, oxytetracyclinum – Oxycort spray) were admini-
strated through the surgery wound and the animals were 
allowed to recover. After 14 days after urethral ligature, 
HRV recording was taken.
Control group: 15 rats underwent sham surgery in which 
the urethra was circumferentially dissected but not ligated. 
The other surgery and post-surgery protocol was similar 
to BOO animals. The HRV study was also carried out 2 
weeks after the sham procedure.
HRV studies: Under urethane anaesthesia (1200mg/
kg body weight; Sigma-Aldrich) ECG recordings were 
taken during 20-minute rest periods in each studied 
animal. This anaesthetic agent was chosen having taken 
into consideration the literature reports which sugge-
sted the proportional (up to the applied dose) impact 
on tonic activity of both, sympathetic and parasym-
pathetic ANS parts and relatively small influence on 
cardiac reflexes [19,20]. After terminating the ECG 
registration and extrasinusal extopics elimination, an 
HRV analysis was performed. Standard time (mNN, 
SDNN, maxNN, min NN – all in [ms], rMSSD and 
mean HR [bpm]) and spectral (frequency; TP, VLF, 
LF, HF – all in [ms*ms] and normalised nLF and nHF 
in [n.u.]) parameters were calculated. The frequency 
range for respective spectral components was set as: 
0,18<VLF<0,28<LF<0,78<HF<3 and commonly accep-
ted interpretation criteria were admitted, as previously 
mentioned in the Introduction. Results were presented 
as mean values ± SD. 
Statistical HRV parameters analysis: The statistical as-
sessment of the results obtained in paired studied groups 
(BOO vs. control) was conveyed after expressing them as 
LN values using parametric Fischer-Snedecor test with 
α=0.05. The expression of the spectral parameter values 
in the form of their natural logarithms was the conse-
quence of the lack of their normal distribution. The H0 
hypothesis of equality of analysed parameter variations 
in two studied populations was verified versus an alterna-
tive H1 hypothesis which assumed their inequality (and 
thus, the existence of statistically significant differences). 
The results of the statistical HRV parameter analysis are 
given in the table 1 below. 
Table 1. Statistical analysis of obtained HRV parameters
PARAMETER
Groups Statistical 
analysisBOO control 
ln mNN 5.15 ± 0.07 5.09 ± 0.06 p=0.076
ln max NN 5.24 ± 0.009 5.24 ± 0.001 p=0.244
ln min NN 5.02 ± 0.11 4.94 ± 0.002 p=0.021
ln SDNN 1.84 ± 0.68 2.12 ± 0.35 p=0.161
ln HR 5.85 ± 0.07 5.91 ± 0.06 p=0.076
ln RMSSD 1.41 ± 1.26 2.42 ± 0.64 p=0.043
ln TP 2.06 ± 1.77 3.46 ± 0.59 p=0.027
ln VLF 1.89 ± 1.84 2.56 ± 1.16 p=0.208
ln LF -1.11 ± 2.00 1.60 ± 0.47 p=0.002
ln HF -0.88 ± 1.80 2.18 ± 0.86 p=0.001
ln LF/HF -0.23 ± 0.86 -0.58 ± 0.68 p=0.213
ln nLF [n.u.] 3.71 ± 0.49 3.54 ± 0.37 p=0.237
ln nHF [n.u.] 3.94 ± 0.37 4.12 ± 0.31 p=0.189
Bladder overactivity assessment: After terminating the 
HRV registration, still under the conditions of urethane 
general anaesthesia, 30-minutes-lasting urodynamical 
recordings were taken to confirm bladder overactivity.
Urethane was used again, after taking into considera-
tion its also re latively small potential for the impairment 
of the urina ry bladder motility, as described previously 
[19,20]. In an anaesthetised rat, the abdomen was ope-
ned through the low midline abdominal incision and 
the obstructed (BOO group) or sham-operated (con-
trol one) urinary bladder was exposed. The polyethylene 
catheter (external diame ter 0.97 mm/internal diameter 
0.58 mm, BALT Poland), connected to pressure trans-
ducer with analysis hardware (Power Lab; Chart 5 Pro 
v.5.4.2, ADInstruments) and in jection pump (Unipan 
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340A), was inserted into the dome of the bladder through 
a small incision. The catheter was fixed in place with silk 
ligature 4-0. Cathetered bladders were left for 15 minu-
tes to stabilise. To begin with, after system calibration, 
the baseline recordings were taken at room temperature 
during continuous saline infusion of 0.046 ml/min for 
30 minutes. Selected standard urodynamic parameters 
were analysed to confirm overreactivity of the bladder 
contractility: peak number (PN), peak number per mi-
nute (PNM), intercontraction interval (ICI [s]) and mic-
turition voiding pressure (MVP [cm H2O]). During the 
experiment the animals were kept under a heating lamp 
to prevent a fall in body temperature.
The examples of resting urodynamic recordings obtained 
in both control (figure 1) and BOO studied ani mals (fi-
gure 2) are given below. 
Fig. 1. The example of urodynamic recordings obtained in control rats
Fig. 2.  The example of urodynamic recordings, supporting bladder motor function 
overactivity, obtained in BOO rats
Taking into consideration the inspection of the visual 
urodynamical records as well as the calculated urodyna-
mical parameter values, we were able to assure that BOO 
animals display urodynamical OAB findings. In this gro-
up, we observed increased PN, PNM with decreased ICI 
and MVP, as compared to the control group.
The control rats (group 1) demonstrated normal bladder 
activity, being an indi rect next evidence of bladder ove-
ractivity recorded in BOO animals.
Urinary bladder assessment: In both BOO and in the 
control group, the bladders were collected once the uro-
dynamic recordings had been taken and  a lethal sodium 
pentobarbital dose (100mg/kg body weight) was admini-
stered. In BOO animals, before bladder excision, the li-
gature around the urethra was carefully removed. In both 
studied groups, urinary bladders were red, swollen and in 
most cases covered by abundant serosal petechial suffu-
sions. Histological inflammatory changes with leucocytes 
infiltration of the bladder wall were demonstrated in BOO 
animals. The control rats had normal bladders.
results
HRV time-domain parameters: Most of the obtained time 
HRV analysis results were insignificant, except min NN 
and rMSSD. Minimal NN reached higher values in BOO 
animals (152,64±16,72) and reached lesser values in con-
trol ones (139,28±3,67). Contrary to the findings mentio-
ned above, rMSSD reached higher value in control group 
(13,01±7,35), while it was almost twice lesser (6,92±8,26) 
in BOO.
When analysing the general trend observed in other time-
-domain HRV parameters, it should be emphasised that 
some of them (max NN, mean HR) were almost identical 
in both studied populations, either increased (SDNN) or 
decreased (mean NN) in control rats.
HRV spectral-domain parameters: The statistical es-
timation of calculated spectral HRV analysis parame-
ters indicated differences relating to the non-normali-
sed power components – LF and HF, as well as to the 
total spectral powers in two compared groups. Gene-
rally, the total power spectrum (TP) and its compo-
nents were lower in BOO animals. A considerable fall 
of LF (1,31±1,79 vs 5,40±2,54) and HF (0,98±0,96 vs. 
11,47±8,89) appeared in the analysis of BOO rats in 
comparison to those from the control group. These para-
meters in this group reached only 24% and 8,5%, respec-
tively, with the control group results adopted as reference 
ones. Contrariwise, normalised (nLF and nHF) spectral 
parameters displayed similar values without statistical 
significance, although nLF was higher in the BOO gro-
up (45,2±19,67 vs. 36,61±16,04) and nHF in the control 
one (63,39±16,04 vs. 54,8±16,72). 
The absolute VLF value was almost the same in both stu-
died populations (20,87±30,33 in BOO vs. 19,22±15,74 in 
control). However, the percentage of this component diffe-
red considerably in both studied groups. In BOO animals, 
the VLF percentage amounted to about 90%, whereas in 
control animals this parameter reached about 53% in re-
lation to the appropriate total power.
The results mentioned above are given in the table 2 below.
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dIscussIon
The key finding of our work was the development of au-
tonomic disturbances in bladder outlet obstruction rats 
(BOO). Our study revealed that BOO animals were cha-
racterised by diminished parameters such as: rMSSD and 
TP, LF and HF, when compared to those from the control 
group. A common agreement exists that rMSSD and HF 
are strongly dependent on parasympathetic drive, while 
LF reflects both sympathetic and parasympathetic activi-
ty. Total power (TP) represents global autonomic tension. 
[12,14] Thus, our findings may suggest decreasing para-
sympathetic activity that is responsible for both rMSSD 
and HF fall while also contributing to LF and TP decrease. 
The next, indirect evidence, confirming parasympathetic 
withdrawal in BOO rats, is the trend in normalised spec-
tral parameters, namely, slight changes in the nLF (incre-
ased) and nHF (decreased), although these differences were 
not statistically significant. Thus, to sum up, our findings 
suggest autonomic imbalance with diminished parasym-
pathetic activity and decreased global autonomic tension.
A reduction of HRV was primarily observed mostly in car-
diological diseases - it has been reported in patients with 
myocardial infarction, chronic heart failure, and in those 
after cardiac transplantation. Similarly, the HRV decrease 
was also described in patients with diabetes being a marker 
of the developing autonomic neuropathy [21,30].
In the field of urology, the ANS assessment and HRV 
studies are scant. In one study, Choi et al [4] defined auto-
nomic status in OAB patients. They showed both SDNN 
and rMSSD decrease through time domain HRV analysis. 
Also, spectral parameters: TP, VLF and HF were found to 
be diminished, with no significant change in LF and LF/
HF, compared to control subjects. Thus, Choi et al. [4] de-
monstrated that female OAB patients, exhibited both time 
and spectral lowered HRV parameters (with the exception 
of LF and LF/HF) which served as evidence of autonomic 
imbalance in this population. In another study by Juszczak 
et al [14], performing autonomic Ewing’s battery tests reve-
aled an overstimulation of the sympathetic tension in male 
OAB patients with benign prostatic hyperplasia (BPH) in 
resting conditions. Moreover, they demonstrated impaired 
parasympathetic response to stimulation, demonstrating 
mixed autonomic disturbances in BPH [14].
It is difficult to compare clinical and experimental results, 
however, our findings are generally consistent with the re-
sults quoted above. Again, we have revealed the diminished 
values of main HRV spectral parameters in BOO model 
Table 2. Analyzed HRV time- and frequency (spectral) parameters
TIME DOMAIN PARAMETERS
Groups Statistical significance 
(for ln values)BOO control
mean NN [ms] 173.03 ± 11.88 163.41 ± 10.27 NS
SDNN 7.43 ± 3.96 8.70 ± 2.73 NS
max NN [ms] 188.34 ± 11.71 188.76 ± 8.28 NS
min NN [ms] 152.64 ± 16.72 139.28 ± 3.67 *
mean HR [bpm] 348.29 ± 25.26 368.32 ± 22.55 NS
rMSSD 6.92 ± 8.26 13.01 ± 7.35 *
SPECTRAL DOMAIN PARAMETERS
Groups Statistical analysis
(for ln values)
BOO control
TP [ms2] 23.16 ± 32.56 36.09 ± 17.83 *
VLF [ms2] 20.87 ± 30.33 19.22 ± 15.74 NS
LF [ms2] 1.31 ± 1.79 5.40 ± 2.54 **
HF [ms2] 0.98 ± 0.96 11.47 ± 8.89 **
LF/HF 1.06 ± 0.75 0.70 ± 0.63 NS
nLF [n.u.] 45.2 ± 19.67 36.61 ± 16.04 NS
nHF [n.u.] 54.8 ± 16.72 63.39 ± 16.04 NS
Legends:
* - statistical significance with p<0.05
** - statistical significance with p<0.01
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that indicate a parasympathetic withdrawal and decrease 
global autonomic activity.
Moreover, in our opinion, the VLF percentage in the global 
power spectrum is also worth taking into consideration. In 
BOO, a relative percentage increase of VLF, comparing to 
other spectrum components, was observed. However, it is 
difficult to interchangeably discuss, whether more heightened 
sympathetic or parasympathetic activity contributes to obse-
rved VLF changes, due to still unknown VLF background 
which warrants further elucidation. According to reference 
books, the VLF component is regarded to reflect circadian 
and neuroendocrine rhythms, thermoregulatory processes, 
the renin-angiotensin system activity, as well as hemodynamic 
feedback delays. Regardless of the VLF origin mechanisms, 
a great interest in this component exists, combined with the 
observations that slow rhythms (VLF and even ultra low fre-
quencies - ULF) are predictors of severe cardiac complications, 
including cardiac death [2,21]. Thus, clear VLF meaning is 
still unknown, although most HRV authorities recommend 
considering this component as a marker of sympathetic ac-
tivity. Accordingly, our VLF findings, observed in BOO rats, 
may result from sympathetic overactivity together with para-
sympathetic withdrawal, as it has already been stated above.
Again, these findings are consistent with other clinical 
reports. Mc Vary et al. [22] and previously Meigs et al. 
[23] found that BPH patients are more likely to have in-
creased sympathetic activity and revealed a relationship 
between BPH development and sympathetic overactivity. 
These authors hypothesised that ANS disturbances may 
have a casual role in the symptomatic development and 
progression of BPH.
On the other hand, however, there are also premises sugge-
sting that VLF is to be regarded as the marker of parasym-
pathetic stimulation. According to Taylor et al [32], VLF 
depends primarily on the presence of parasympathetic out-
flow. They showed that atropine almost abolishes VLF power 
and other spectral components, suggesting that HRV, also 
in the VLF band, is driven by parasympathetic modulation. 
Soares et al [29] demonstrated in experimental study that 
pyridostigmine (a reversible cholinoesterase inhibitor) sti-
mulation produced strongly emphasised VLF increase [7]. 
Eckberg and Kuusela [10] studied rhythmical variation in 
arterial pressure, depending on vagal baroreflex activity. The-
ir analysis indicated that baroreflex sensitivity fluctuations 
(expressed as a percentages of the total power) concentrated 
more in very low frequencies. They also revealed that the 
periodicity of very low frequency baroreflex sensitivity fluc-
tuations was not influenced significantly by upright tilt test 
that is considered to be mediated by the sympathetic drive. 
Thus, according to Eckberg and Kuusela [10], human vagal 
baroreflex activity is reflected mostly at very low frequencies.
Therefore, the prognostic value of VLF oscillations may de-
rive from the fundamental importance of parasympathetic 
mechanisms. From this point of view, our VLF findings 
would be contrary to the previously described TP, LF and 
HF results interpretation. Together with the decrease of 
the HF and nHF parameters, reflecting diminished pa-
rasympathetic drive, we would expect the simultaneous 
VLF decrease. Hence, the relatively high VLF percentage 
observed in the BOO group, may be rather due to possibly 
sympathetic predominance.
In conclusion, we revealed, that short-term animal model of 
partial bladder obstruction, is associated with ANS abnor-
malities, including parasympathetic withdrawal and relative 
sympathetic predominance. It is questionable, if these findings 
may be directly extrapolated to clinical conditions. There are 
limitations in experimental studies interpretation in relation 
to clinical deduction. Ideally, animal model should reproduce 
all the facets of the human condition but it is inconceivable 
that any animal model will replicate all the symptoms, me-
chanisms and consequences of a disease. A model is usually 
only relevant for a limited number of aspects of the human 
conditions and it is rather a tool tailored to answer a particular 
experimental hypothesis. Additionally, research into bladder 
overactivity is also hampered by the lack of a bladder or se-
rum specific biomarker that would reflect the disease process 
[26]. Thus, taking into account these limitation aspects and 
given the likely multifactoral OAB aethiology, it seems that 
our study should be followed by clinical research to confirm 
if similar ANS abnormalities are observed in BOO patients 
as those observed by us in animals.
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